Navigation Links
Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
Date:9/12/2007

search platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company's primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and various diseases. For more information please visit: http://www.rosettagenomics.com

Contact:

Media

Alan Zachary

T: +1-312-944-6784

media@rosettagenomics.com

Investors

Juliane Snowden

T: +1-212-213-0006

investors@rosettagenomics.com


'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
2. Genomics researcher Hood joins NimbleGen board
3. GE Healthcare partners with genomics institute
4. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
5. Wisconsin firms to present at Cleantech venture capital event
6. New Sonic Foundry search engine finds words, phrases in video presentations
7. Lone Wisconsin firm to present at InvestMidwest
8. Sonic Foundry creates search engine for 7,000 expert video presentations
9. InvestMidWest calls for business presentations
10. Wicab to present BrainPort at Boston conference
11. Three more Wisconsin firms to present at venture forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Shire plc (LSE: SHP, Nasdaq: SHPGY ), ... recall of five lots and voluntary market withdrawal of ... ® . Shire is taking this action because some ... may not meet their release liner removal specification, and ...
(Date:12/3/2009)... 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief ... http://www.beikebiotech.com ), spoke at a conference on ... 22, 2009. Beike is China,s leading,stem cell research ... The conference, organized by the Indian Podiatry ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Carbondioxide Incubators - A Global Market ... ,, Incubators are the most critical equipment ... other applications for providing a controlled environment ...
(Date:12/2/2009)... 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) ... confirmation and dosimetry trial of Cotara® in patients with ... cancer. Cotara is a targeted monoclonal antibody linked ... treatment for GBM. Cotara specifically targets cells at ...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... Epeius Biotechnologies,Corporation today announced that Rexin-G has ... and Drug Administration (FDA) for the,treatment of all ... third,clinical indication for which Rexin-G has been formally ... latest approval for Rexin-G validates the,company,s remarkable strategy ...
... 8, 2008Biotech and pharmaceutical firms are developing a ... complicated drug discovery process, reports Genetic Engineering ... successful approaches rely on a combination of high-throughput ... according to an article in the July issue ...
... in nanoscale lithographic technology, used in the manufacture of ... patterns of lines over larger areas than have been ... could pave the way for next-generation computer memory and ... other devices. , The team has created lines about ...
Other Biology Technology:FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 2FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 3MIT reports finer lines for microchips 2
(Date:12/3/2009)... solar panels that repels grime and dirt? Expanded battery ... Aviv University research, just published in Nature Nanotechnology ... nano-scale level that could make these futuristic visions come ... the range of 100 nanometers (roughly one-billionth of a ...
(Date:12/3/2009)... change in warmer water, according to an intriguing new study ... , Experiments with two species of young damselfish on Australia,s ... some reef fish are either consistently timid, or consistently bold, ... water temperatures rise. , A slight lift of just one ...
(Date:12/3/2009)... A team of scientists from the U.S. Department ... the Indian Institute of Science has made a major ... in DNA that is necessary to carry out important ... 2009 edition of Nature Structural & Molecular Biology ...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3HealthFitness Makes Compelling Case for Employee Health Management 51822 1HealthFitness Makes Compelling Case for Employee Health Management 51822 2Immunoassay at AACC 2009 3A Tosoh Launches AIA 2000 Automated Immunoassay Analyzer 51819 1Immunoassay at AACC 2009 3A Tosoh Launches AIA 2000 Automated Immunoassay Analyzer 51819 2St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 1St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 2St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 3St Jude Scientists Discover a New Mechanism Controlling Neuronal Migration 51816 4
... Called granulosa cells, they surround eggs and deliver nutrients ... be successfully fertilized. , How do these handmaidens grow? ... have discovered that two proteins ?TAF4b and c-Jun ?team ... the nuclei of granulosa cells. This subset of genes, ...
... bone-marrow derived stem cells can regenerate damaged renal cells ... potential new strategy for managing this inherited kidney disease ... may be useful in repairing basement membrane matrix defects ... at Beth Israel Deaconess Medical Center (BIDMC), the findings ...
... sea experiments shows there's a constant shuffling of genetic ... they use seems to be a flood of viruses, ... Professor Sally W. Chisholm, is uncovering a challenging new ... manage to exploit changing conditions such as altered light, ...
Other Biology News:A surprising pair of proteins help make healthy eggs 2New research demonstrates bone-marrow derived stem cells can reverse genetic kidney disease 2MIT: Oceans are a major gene swap-meet for plankton 2MIT: Oceans are a major gene swap-meet for plankton 3MIT: Oceans are a major gene swap-meet for plankton 4
... Mouse monoclonal [YPF19] to Yersinia ... to detect Yersinia pestis . ... from Yersinia pestis vaccine ... This antibody recognises Y.pestis F1 capsular ...
Rabbit polyclonal to ZFP200 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGKSFNHKTNLNKHER (Human) Entrez Gene ID: 7752 Swiss Protein ID: P98182...
Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
Rabbit polyclonal to Leucyl tRNA synthetase ( Abpromise for all tested applications). Antigen: L930-H1176 denatured human recombinant LRS. Entrez Gene ID: 3926 Swiss Protein ID: Q9P2J5...
Biology Products: